Show
Sort by
-
The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentric cohort study
-
A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)
-
Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial
-
Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study
(2021) UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. In United European Gastroenterology Journal 9(S1). p.554-555